Logo image of PZN

PZENA INVESTMENT MANAGM-CL A (PZN) Stock Fundamental Analysis

NYSE:PZN - New York Stock Exchange, Inc. - US74731Q1031 - Common Stock - Currency: USD

9.65  +0.04 (+0.42%)

After market: 9.65 0 (0%)

Fundamental Rating

2

Taking everything into account, PZN scores 2 out of 10 in our fundamental rating. PZN was compared to 230 industry peers in the Capital Markets industry. PZN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PZN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PZN was profitable.
PZN Yearly Net Income VS EBIT VS OCF VS FCFPZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

1.2 Ratios

Industry RankSector Rank
ROA 4.61%
ROE 32.1%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PZN Yearly ROA, ROE, ROICPZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 10 20 30 40 50

1.3 Margins

PZN's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of PZN has grown nicely.
Industry RankSector Rank
OM 48.23%
PM (TTM) 6.5%
GM N/A
OM growth 3Y10.34%
OM growth 5Y17.53%
PM growth 3Y10.62%
PM growth 5Y2.89%
GM growth 3YN/A
GM growth 5YN/A
PZN Yearly Profit, Operating, Gross MarginsPZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

PZN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PZN has an improved debt to assets ratio.
PZN Yearly Shares OutstandingPZN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
PZN Yearly Total Debt VS Total AssetsPZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

There is no outstanding debt for PZN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
PZN Yearly LT Debt VS Equity VS FCFPZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

2

3. Growth

3.1 Past

The earnings per share for PZN have decreased strongly by -28.57% in the last year.
The Earnings Per Share has been decreasing by -1.14% on average over the past years.
The Revenue has been growing slightly by 3.60% in the past year.
PZN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.98% yearly.
EPS 1Y (TTM)-28.57%
EPS 3Y5.03%
EPS 5Y-1.14%
EPS Q2Q%-44.44%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y9.08%
Revenue growth 5Y12.98%
Sales Q2Q%-12.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.32%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PZN Yearly Revenue VS EstimatesPZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
PZN Yearly EPS VS EstimatesPZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.79, PZN is valued correctly.
Compared to an average S&P500 Price/Earnings ratio of 26.70, PZN is valued a bit cheaper.
Industry RankSector Rank
PE 13.79
Fwd PE N/A
PZN Price Earnings VS Forward Price EarningsPZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.59
PZN Per share dataPZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

PZN has a Yearly Dividend Yield of 1.25%.
With a Dividend Yield of 1.25, PZN pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.25%

5.2 History

The dividend of PZN decreases each year by -12.64%.
PZN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-12.64%
Div Incr YearsN/A
Div Non Decr YearsN/A
PZN Yearly Dividends per sharePZN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

4.08% of the earnings are spent on dividend by PZN. This is a low number and sustainable payout ratio.
PZN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP4.08%
EPS Next 2YN/A
EPS Next 3YN/A
PZN Yearly Income VS Free CF VS DividendPZN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
PZN Dividend Payout.PZN Dividend Payout, showing the Payout Ratio.PZN Dividend Payout.PayoutRetained Earnings

More info and screens

PZENA INVESTMENT MANAGM-CL A

NYSE:PZN (10/28/2022, 8:04:00 PM)

After market: 9.65 0 (0%)

9.65

+0.04 (+0.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-19 2022-10-19/amc
Earnings (Next)01-30 2023-01-30
Inst Owners0.03%
Inst Owner Change-81.72%
Ins Owners6.59%
Ins Owner Change0%
Market Cap710.99M
Analysts45
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.25%
Yearly Dividend0.34
Dividend Growth(5Y)-12.64%
DP4.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.79
Fwd PE N/A
P/S 3.6
P/FCF N/A
P/OCF N/A
P/B 17.76
P/tB 17.76
EV/EBITDA 6.59
EPS(TTM)0.7
EY7.25%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.68
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.61%
ROE 32.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 48.23%
PM (TTM) 6.5%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.34%
OM growth 5Y17.53%
PM growth 3Y10.62%
PM growth 5Y2.89%
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)54.07%
Cap/Depr(5y)42.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)631.25%
Profit Quality(5y)699.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3Y5.03%
EPS 5Y-1.14%
EPS Q2Q%-44.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.6%
Revenue growth 3Y9.08%
Revenue growth 5Y12.98%
Sales Q2Q%-12.36%
Revenue Next Year6.32%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.18%
FCF growth 3Y-4.42%
FCF growth 5Y5.51%
OCF growth 1Y50.02%
OCF growth 3Y-4.28%
OCF growth 5Y5.6%